OPEN END TURBO OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000JC1HWK2

Real-time Bid/Ask 08:37:05 29/05/2024 pm IST
3.3 EUR / 3.31 EUR +2.32% Intraday chart for OPEN END TURBO OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-2.71%
1 month-8.76%
Date Price Change
29/24/29 3.3 +2.17%
28/24/28 3.23 -1.52%
27/24/27 3.28 +1.23%
24/24/24 3.24 -2.70%
23/24/23 3.33 +1.22%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 08:18 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer J.P. Morgan
WKN JC1HWK
ISINDE000JC1HWK2
Date issued 26/05/2020
Strike 71.53
Maturity Unlimited
Parity 10 : 1
Emission price 1.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.85
Lowest since issue 0.68
Spread 0.01
Spread %0.30%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.32 EUR
Average target price
39.84 EUR
Spread / Average Target
+1.33%
Consensus